Anorexia Research Study
Researchers at the University of California, San Diego are investigating a treatment drug for individuals diagnosed with anorexia nervosa (AN).
Fast Facts
Diagnosed with anorexia nervosa
18+ years old
Compensation Provided
Conducted in West Coast, US
Study Background
Researchers at the University of California, San Diego are investigating a treatment drug for individuals diagnosed with anorexia nervosa (AN).
This study aims to see if a drug called COMP360, along with psychological support, can help treat anorexia nervosa (AN).
COMP360 is made in a lab and is similar to a chemical found in some mushrooms called psilocybin. Some studies suggest psilocybin might help with anorexia nervosa symptoms. COMP360 works by affecting the serotonin system in the brain, which helps control mood.
By testing COMP360 with psychological support, this study hopes to learn more about how it could help people with anorexia nervosa feel better and improve their mental health.
Study Background
Researchers at the University of California, San Diego are investigating a treatment drug for individuals diagnosed with anorexia nervosa (AN).
This study aims to see if a drug called COMP360, along with psychological support, can help treat anorexia nervosa (AN).
COMP360 is made in a lab and is similar to a chemical found in some mushrooms called psilocybin. Some studies suggest psilocybin might help with anorexia nervosa symptoms. COMP360 works by affecting the serotonin system in the brain, which helps control mood.
By testing COMP360 with psychological support, this study hopes to learn more about how it could help people with anorexia nervosa feel better and improve their mental health.
Additional Information
You may be eligible to participate if you meet the following criteria:
Inclusion Criteria:
- 18 years or above
- Active diagnosis of anorexia nervosa with a duration of at least 3 years and at least one attempt at treatment within the last 3 years
- BMI of 15.0-18.5
- Resting heart rate of 50 BPM or above
- Deemed medically stable
Exclusion Criteria:
- Bipolar, personality, schizoaffetive, psychotic, or antisocial personality disorders
- Exposure to psychedelics within the last year
- History of epilepsy or seizures
If you choose to participate in this study, you will be involved for about 4-5 months. During this time, you will have in-person appointments almost every week until the fourth week follow-up, after which they will be scheduled every other week.
The study will start with a screening visit to check if you meet the requirements. After this, there will be a screening period lasting 2-5 weeks.
Following the screening period, there will be a dosing week involving three consecutive visits. After the dosing week, there will be a 12-week follow-up period where you will have regular appointments to monitor your progress.
As a participant, you can receive up to $80 per visit, as well as some travel and meal reimbursement.
There is no cost for you to participate in our research study.